The Bacillus Calmette-Guérin (BCG) vaccine, which has been around for over a century and is known for enhancing the body's immunity against tuberculosis and other diseases, is a potential breakthrough in treating hepatocellular carcinoma (HCC).
HCC is the most common type of liver cancer and the third leading cause of cancer-related deaths globally.
According to the North American Association of Central Cancer Registries, an estimated 41,210 new HCC cases would be diagnosed in the United States in 2023.
Old Vaccine Potentially Treats Liver Cancer
Maternal Booster COVID-19 Vaccination Protects Infants Through 6 Months
For each 10-fold increase in Spike IgG titer at delivery, risk for infection reduced 47 percent for infants, regardless of boost
Florida Surgeon General Defies CDC Guidance Amid School Measles Outbreak
By Robin Foster HealthDay Reporter FRIDAY, Feb. 23, 2024 (HealthDay News) — Amid an outbreak of measles at a Florida elementary school, the state’s surgeon general has defied federal health …